# Contraceptive Effectiveness and Safety of the SILCS Diaphragm

> **NCT00578877** · PHASE2,PHASE3 · COMPLETED · sponsor: **CONRAD** · enrollment: 450 (actual)

## Conditions studied

- Contraception

## Interventions

- **DEVICE:** SILCS Diaphragm
- **COMBINATION_PRODUCT:** Nonoxynol-9 Gel
- **COMBINATION_PRODUCT:** Buffer Gel

## Key facts

- **NCT ID:** NCT00578877
- **Lead sponsor:** CONRAD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2018-03-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578877, "Contraceptive Effectiveness and Safety of the SILCS Diaphragm". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00578877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*